nach oben

Erschienen in:

01.06.2019 | Case report

Colchicine

Lymphopenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A study of 213 patients, who were followed at Hacettepe University Department of Pediatric Rheumatology, Turkey between July 2018 and September 2018, a patient [age and sex not stated] was described, who developed lymphopenia during treatment with colchicine for familial mediterranean fever (FMF). …

Sag E, et al. Does colchicine really cause leukopenia?. Pediatric Rheumatology 17 (Suppl. 1): 144-145 abstr. P2087, 2019. Available from: URL: http://doi.org/10.1186/s12969-019-0313-x [abstract] - Turkey

Titel: Colchicine
Lymphopenia: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63968-9

Meropenem/tigecycline interaction

Case report

Cardiovascular AEs more common with carfilzomib than bortezomib

Clinical study

Antivirals

Case report

Foscarnet

Case report

Alemtuzumab

Case report

Anakinra/dexamethasone

Case report

Springer Medizin

Colchicine

Lymphopenia: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Meropenem/tigecycline interaction

Cardiovascular AEs more common with carfilzomib than bortezomib

Antivirals

Foscarnet

Alemtuzumab

Anakinra/dexamethasone

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Meropenem/tigecycline interaction

Cardiovascular AEs more common with carfilzomib than bortezomib

Antivirals

Foscarnet

Alemtuzumab

Anakinra/dexamethasone